Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Association of rhinitis with asthma prevalence and severity. PMID: 35430600 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Apr 16;12(1):6389. doi: 10.1038/s41598-022-10448-w. Impact factor: 4.38 Publication type: Paper in international publication Authors: Acevedo-Prado, Antonio, Seoane-Pillado, Teresa, Lopez-Silvarrey-Varela, Angel, Salgado, Francisco-Javier, Cruz, Maria-Jesus, Faraldo-Garcia, Ana, Nieto-Fontarigo, Juan-Jose, Pertega-Diaz, Sonia, Sanchez-Lastres, J, San-Jose-Gonzalez, Miguel-Angel et al. DOI: 10.1038/s41598-022-10448-w Association of rhinitis with asthma prevalence and severity. PMID: 35430600 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Apr 16;12(1):6389. doi: 10.1038/s41598-022-10448-w. Impact factor: Publication type: Paper in international publication Authors: Acevedo-Prado, Antonio; Bamonde-Rodriguez, Luis; Cruz, Maria-Jesus; Faraldo-Garcia, Ana; Garnelo-Suarez, Luciano; Gonzalez-Barcala, Francisco-Javier; Lopez-Silvarrey-Varela, Angel; Nieto-Fontarigo, Juan-Jose; Perez-Castro, Teresa; Pertega-Diaz, Sonia et al. DOI: 10.1038/s41598-022-10448-w Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma. PMID: 36155169 Journal: Clinical Genitourinary Cancer Year: 2022 Reference: Clin Genitourin Cancer. 2022 Dec;20(6):558-567. doi: 10.1016/j.clgc.2022.08.006. Epub 2022 Aug 19. Impact factor: Publication type: Paper in international publication Authors: Agarwal, Neeraj; Alva, Ajjai; Bamias, Aristotelis; Barata, Pedro; Bilen, Mehmet A; Buznego, Lucia Alonso; Carril-Ajuria, Lucia; Castellano, Daniel; Cortellini, Alessio; Dawsey, Scott et al. DOI: 10.1016/j.clgc.2022.08.006 Association of Tumor Mutational Burden with Efficacy of Pembrolizumab{plus minus}Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. PMID: 35657979 Journal: CLINICAL CANCER RESEARCH Year: 2022 Reference: Clin Cancer Res. 2022 Jun 3. pii: 699374. doi: 10.1158/1078-0432.CCR-22-0121. Impact factor: 12.531 Publication type: Paper in international publication Authors: Cao, Z Alexander, Aurora-Garg, Deepti, Kobie, Julie, Cristescu, Razvan, Bhagia, Pooja, Shah, Sukrut, Tabernero, Josep, Shitara, Kohei, Wyrwicz, Lucjan, Wainberg, Zev A et al. DOI: 10.1158/1078-0432.CCR-22-0121 Association of Tumor Mutational Burden with Efficacy of Pembrolizumab{plus minus}Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. PMID: 35657979 Journal: CLINICAL CANCER RESEARCH Year: 2022 Reference: Clin Cancer Res. 2022 Aug 15;28(16):3489-3498. doi: 10.1158/1078-0432.CCR-22-0121. Impact factor: Publication type: Paper in international publication Authors: Aurora-Garg, Deepti; Bang, Yung-Jue; Bhagia, Pooja; Cao, Z Alexander; Castro, Hugo R; Chao, Joseph; Chung, Hyun Cheol; Cristescu, Razvan; Fuchs, Charles S; Garrido, Marcelo et al. DOI: 10.1158/1078-0432.CCR-22-0121 Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders. PMID: 34711650 Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Year: 2022 Reference: J Neurol Neurosurg Psychiatry. 2022 Feb;93(2):188-195. doi: 10.1136/jnnp-2021-327412. Epub 2021 Oct 28. Impact factor: 10.283 Publication type: Paper in international publication Authors: Radaelli, Marta, Lu, Angelo, Zimmermann, Hanna G, Specovius, Svenja, Motamedi, Seyedamirhosein, Chien, Claudia, Bereuter, Charlotte, Lana-Peixoto, Marco A, Fontenelle, Mariana Andrade, Ashtari, Fereshteh et al. DOI: 10.1136/jnnp-2021-327412 Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders. PMID: 34711650 Journal: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY Year: 2022 Reference: J Neurol Neurosurg Psychiatry. 2022 Feb;93(2):188-195. doi: 10.1136/jnnp-2021-327412. Epub 2021 Oct 28. Impact factor: Publication type: Paper in international publication Authors: Aktas, Orhan; Albrecht, Philipp; Altintas, Ayse; Asgari, Nasrin; Ashtari, Fereshteh; Bereuter, Charlotte; Bichuetti, Denis Bernardi; Brandt, Alexander U; Chien, Claudia; Cobo-Calvo, Alvaro et al. DOI: 10.1136/jnnp-2021-327412 Asymptomatic carriers of mutations in succinate dehydrogenase (SDHx) genes. In search of consensus for follow-up. PMID: 35353683 Journal: Endocrinologia Diabetes y Nutricion Year: 2022 Reference: Endocrinol Diabetes Nutr (Engl Ed). 2022 Mar;69(3):157-159. doi: 10.1016/j.endien.2022.01.008. Epub 2022 Mar 4. Impact factor: 1.417 Publication type: Editorial in national publication Authors: Navarro Gonzalez, Elena, Romero Lluch, Ana, Casteras Roman, Anna et al. DOI: 10.1016/j.endien.2022.01.008 Asymptomatic carriers of mutations in succinate dehydrogenase (SDHx) genes. In search of consensus for follow-up. PMID: 35353683 Journal: Endocrinologia Diabetes y Nutricion Year: 2022 Reference: Endocrinol Diabetes Nutr (Engl Ed). 2022 Mar;69(3):157-159. doi: 10.1016/j.endien.2022.01.008. Epub 2022 Mar 4. Impact factor: Publication type: Editorial in national publication Authors: Casteras Roman, Anna; Navarro Gonzalez, Elena; Romero Lluch, Ana et al. DOI: 10.1016/j.endien.2022.01.008 Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial. PMID: 35995953 Journal: NATURE MEDICINE Year: 2022 Reference: Nat Med. 2022 Sep;28(9):1831-1839. doi: 10.1038/s41591-022-01933-w. Epub 2022 Aug 22. Impact factor: Publication type: Paper in international publication Authors: Andric, Zoran; Barrios, Carlos H; Cheema, Parneet; Cobo, Manuel; Danchaivijitr, Pongwut; Dansin, Eric; Dziadziuszko, Rafal; Fabrizio, David A; Felip, Enriqueta; Gadgeel, Shirish M et al. DOI: 10.1038/s41591-022-01933-w ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation. PMID: 35444013 Journal: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Year: 2022 Reference: Int J Gynecol Cancer. 2022 Apr 20. pii: ijgc-2022-003370. doi: 10.1136/ijgc-2022-003370. Impact factor: 3.437 Publication type: Paper in international publication Authors: Garcia-Duran, Carmen, Grau, Francisco, Villacampa, Guillermo, Oaknin, Ana et al. DOI: 10.1136/ijgc-2022-003370 ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation. PMID: 35444013 Journal: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Year: 2022 Reference: Int J Gynecol Cancer. 2022 Sep 6;32(9):1196-1200. doi: 10.1136/ijgc-2022-003370. Impact factor: Publication type: Paper in international publication Authors: Garcia-Duran, Carmen; Grau, Francisco; Oaknin, Ana; Villacampa, Guillermo et al. DOI: 10.1136/ijgc-2022-003370 Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. PMID: 35100023 Journal: CIRCULATION Year: 2022 Reference: Circulation. 2022 Feb;145(5):392-409. doi: 10.1161/CIRCULATIONAHA.121.055018. Epub 2022 Jan 31. Impact factor: 29.69 Publication type: Paper in international publication Authors: Connolly, Stuart, Dagres, Nikolaos, Elkind, Mitchell S V, Engdahl, Johan, Field, Thalia S, Gersh, Bernard J, Glotzer, Taya V, Hankey, Graeme J, Harbison, Joseph A, Georg Haeusler, Karl et al. DOI: 10.1161/CIRCULATIONAHA.121.055018 Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. PMID: 35100023 Journal: CIRCULATION Year: 2022 Reference: Circulation. 2022 Feb;145(5):392-409. doi: 10.1161/CIRCULATIONAHA.121.055018. Epub 2022 Jan 31. Impact factor: Publication type: Paper in international publication Authors: Berge, Trygve; Boriani, Giuseppe; Brandes, Axel; Calkins, Hugh; Camm, A John; Collins, Ronan; Conen, David; Connolly, Stuart; Dagres, Nikolaos; Elkind, Mitchell S V et al. DOI: 10.1161/CIRCULATIONAHA.121.055018 Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. PMID: 35348052 Journal: EUROPEAN PSYCHIATRY Year: 2022 Reference: Eur Psychiatry. 2022 Mar 29:1-18. doi: 10.1192/j.eurpsy.2022.14. Impact factor: 5.361 Publication type: Paper in international publication Authors: Jean, Francois Arnaud Matthieu, Arsandaux, Julie, Montagni, Ilaria, Collet, Ophelie, Fatseas, Melina, Auriacombe, Marc, Ramos-Quiroga, Josep Antoni, Cote, Sylvana M, Tzourio, Christophe, Galera, Cedric et al. DOI: 10.1192/j.eurpsy.2022.14 Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort. PMID: 35348052 Journal: EUROPEAN PSYCHIATRY Year: 2022 Reference: Eur Psychiatry. 2022 Mar 29;65(1):1-18. doi: 10.1192/j.eurpsy.2022.14. Impact factor: Publication type: Paper in international publication Authors: Arsandaux, Julie; Auriacombe, Marc; Collet, Ophelie; Cote, Sylvana M; Fatseas, Melina; Galera, Cedric; Jean, Francois Arnaud Matthieu; Montagni, Ilaria; Ramos-Quiroga, Josep Antoni; Tzourio, Christophe et al. DOI: 10.1192/j.eurpsy.2022.14 Atypical Sympathetic Ophthalmia Presenting with Ocular Pain Associated with Posterior Scleral Involvement. PMID: 33734929 Journal: OCULAR IMMUNOLOGY AND INFLAMMATION Year: 2022 Reference: Ocul Immunol Inflamm. 2022 Aug;30(6):1460-1463. doi: 10.1080/09273948.2021.1891261. Epub 2021 Mar 18. Impact factor: Publication type: Paper in international publication Authors: Aragon, David; Banderas, Sandra; Garrell, Xavier; Iribarren, Maria Del Carmen; Segura, Antonio; Trejo, Fernando et al. DOI: 10.1080/09273948.2021.1891261 Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. PMID: 35474365 Journal: NATURE GENETICS Year: 2022 Reference: Nat Genet. 2022 May;54(5):735. doi: 10.1038/s41588-022-01079-y. Impact factor: 38.33 Publication type: Letter or abstract Authors: Van Dooren, Sonia, Potet, Franck, Offerhaus, Joost A, Walsh, Roddy, Choi, Seung Hoan, Verkerk, Arie O, Mizusawa, Yuka, Anys, Soraya, Minois, Damien, Arnaud, Marine et al. DOI: 10.1038/s41588-022-01079-y Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. PMID: 35474365 Journal: NATURE GENETICS Year: 2022 Reference: Nat Genet. 2022 May;54(5):735. doi: 10.1038/s41588-022-01079-y. Impact factor: Publication type: Letter or abstract Authors: Anselme, Frederic; Antzelevitch, Charles; Anys, Soraya; Arbelo, Elena; Arnaout, Alain Al; Arnaud, Marine; Babuty, Dominique; Barajas-Martinez, Hector; Barc, Julien; Baron, Estelle et al. DOI: 10.1038/s41588-022-01079-y Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER(+) breast cancer. PMID: 36376284 Journal: Nature Communications Year: 2022 Reference: Nat Commun. 2022 Nov 14;13(1):6928. doi: 10.1038/s41467-022-34580-3. Impact factor: Publication type: Letter or abstract Authors: Arnedos, Monica; Arribas, Joaquin; Azaro, Analia; Bellet, Meritxell; Braso-Maristany, Fara; Bruna, Alejandra; Caldas, Carlos; Capelan, Marta; Clarke, Robert B; Dienstmann, Rodrigo et al. DOI: 10.1038/s41467-022-34580-3 Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension. PMID: 35902683 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Jul 28;12(1):12947. doi: 10.1038/s41598-022-17525-0. Impact factor: Publication type: Letter or abstract Authors: Argibay, Ana; Argibay, Ana; Arjona, Josefa Jimenez; Baldomero, Idaira Famara Hernandez; Ballve, Adela Marin; Barbera, Joan Albert; Barbera, Joan Albert; Blanco, Isabel; Blanco, Isabel; Candelera, Remedios Otero et al. DOI: 10.1038/s41598-022-17525-0 Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. PMID: 35449310 Journal: Nature cancer Year: 2022 Reference: Nat Cancer. 2022 May;3(5):649. doi: 10.1038/s43018-022-00378-x. Impact factor: 0 Publication type: Letter or abstract Authors: Ernberg, Ingemar, Frohling, Stefan, Garralda, Elena, Karlsson, Claes, Tabernero, Josep, Voest, Emile, Rodon, Jordi, Lehtio, Janne, Anand, Shubha, Baars, Danny et al. DOI: 10.1038/s43018-022-00378-x Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. PMID: 35449310 Journal: Nature Cancer Year: 2022 Reference: Nat Cancer. 2022 May;3(5):649. doi: 10.1038/s43018-022-00378-x. Impact factor: Publication type: Letter or abstract Authors: Anand, Shubha; Apolone, Giovanni; Baars, Danny; Baird, Richard; Baird, Richard D; Bajalica-Lagercrantz, Svetlana; Balmana, Judith; Bergh, Jonas; Bierkens, Mariska; Blomqvist, Lennart et al. DOI: 10.1038/s43018-022-00378-x Author response to: European Hernia Society guidelines on management of rectus diastasis. PMID: 34791061 Journal: British Journal of Surgery Year: 2022 Reference: Br J Surg. 2022 Feb 1;109(2):e42. doi: 10.1093/bjs/znab393. Impact factor: Publication type: Paper in international publication Authors: Berrevoet, Frederik; Cuccurullo, Diego; Henriksen, Nadia; Hernandez-Granados, Pilar; Lopez-Cano, Manuel; Montgomery, Agneta; Nienhuijs, Simon; Ross, David et al. DOI: 10.1093/bjs/znab393 Pagination First page « First Previous page ‹ Previous … Page 144 Page 145 Page 146 Page 147 Current page 148 Page 149 Page 150 Page 151 Page 152 … Next page Next › Last page Last »
